Literature DB >> 2876944

DNA polymorphism related to the idiopathic hemochromatosis gene: evidence in a recombinant family.

V David, P Paul, M Simon, J Y Le Gall, R Fauchet, I Gicquel, I Dugast, L Le Mignon, J Yaouanq, D Cohen.   

Abstract

The metabolic error involved in idiopathic hemochromatosis, as well as the underlying genetic defect remain unknown. It has, however, been recently shown that this genetic lesion occurs at a locus linked to the major histocompatibility complex, probably close to the HLA-A locus, and that the disease is recessively transmitted. Therefore, in a family where one subject has idiopathic hemochromatosis his HLA-identical siblings should also be affected. We present here the restriction polymorphism with two MHC class I probes and one DR beta probe in an exceptional family with three HLA-identical siblings: one (the proband) has a major form of idiopathic hemochromatosis, while the other two are free of any clinical or biochemical signs of the disease. The restriction patterns observed after DNA digestion by enzymes EcoRI, EcoRV, BglII, BamHI, PvuII, TaqI, HincII, and HindIII led to the conclusion that one of the proband's chromosome 6 had undergone two alterations: one, a deletion in the DR region, was revealed by missing fragments all correlated with DR5; the other was an unbalanced cross-over or a genetic conversion in the MHC class I region. This latter alteration was revealed by modifications in the patterns of high molecular weight HindIII bands which hybridize with probe pHLA2 and also by the absence of a HindIII fragment of 7.4 kb hybridized by another class I probe. This latter alteration most likely involved the hemochromatosis gene and could be the first step toward a molecular approach to this gene.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876944     DOI: 10.1007/bf00282073

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  29 in total

1.  Letter: HLA antigens in haemochromatosis.

Authors:  W G Shewan; S A Mouat; T M Allan
Journal:  Br Med J       Date:  1976-01-31

Review 2.  DNA polymorphism of HLA class I and class II regions.

Authors:  D Cohen; P Paul; I Le Gall; A Marcadet; M P Font; O Cohen-Haguenauer; B Sayagh; H Cann; J M Lalouel; J Dausset
Journal:  Immunol Rev       Date:  1985-07       Impact factor: 12.988

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Isolation and partial nucleotide sequence of a cDNA clone for human histocompatibility antigen HLA-B by use of an oligodeoxynucleotide primer.

Authors:  A K Sood; D Pereira; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

5.  Polymorphic restriction endonuclease fragment segregates and correlates with the gene for HLA-B8.

Authors:  H M Cann; L Ascanio; P Paul; A Marcadet; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

6.  The major histocompatibility complex in man.

Authors:  J Dausset
Journal:  Science       Date:  1981-09-25       Impact factor: 47.728

7.  A highly polymorphic locus in human DNA.

Authors:  A R Wyman; R White
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  HLA typing in idiopathic hemochromatosis: distinction between homozygotes and heterozygotes with biochemical expression.

Authors:  M L Bassett; J W Halliday; L W Powell
Journal:  Hepatology       Date:  1981 Mar-Apr       Impact factor: 17.425

9.  Idiopathic haemochromatosis in the Australian population: HLA linkage and recessivity.

Authors:  T J Doran; H V Bashir; J Trejaut; M L Bassett; J W Halliday; L W Powell
Journal:  Hum Immunol       Date:  1981-05       Impact factor: 2.850

10.  Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees.

Authors:  M M Dadone; J P Kushner; C Q Edwards; D T Bishop; M H Skolnick
Journal:  Am J Clin Pathol       Date:  1982-08       Impact factor: 2.493

View more
  7 in total

Review 1.  Genetic haemochromatosis.

Authors:  A B Bomford; I W Dymock; E B Hamilton
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association.

Authors:  M Simon; L Le Mignon; R Fauchet; J Yaouanq; V David; G Edan; M Bourel
Journal:  Am J Hum Genet       Date:  1987-08       Impact factor: 11.025

3.  Linkage disequilibrium and extended haplotypes in the HLA-A to D6S105 region: implications for mapping the hemochromatosis gene (HFE).

Authors:  G Gandon; A M Jouanolle; B Chauvel; V Mauvieux; A le Treut; J Feingold; J Y Le Gall; V David; J Yaouanq
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

Review 4.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

5.  Detection of hereditary haemochromatosis in an HLA-identical pedigree showing discordance between HLA class I genes and the disease locus.

Authors:  I Dokal; D Lord; D Rhodes; G Bydder; T Cox
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

6.  Anonymous markers located on chromosome 6 in the HLA-A class I region: allelic distribution in genetic haemochromatosis.

Authors:  J Boretto; A M Jouanolle; J Yaouanq; A el Kahloun; V Mauvieux; M Blayau; M Perichon; A Le Treut; J Clayton; N Borot
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

7.  HLA class I gene polymorphism in genetic hemochromatosis.

Authors:  A M Jouanolle; J Yaouanq; M Blayau; M Périchon; R Fauchet; M P Font; J Y Le Gall; V David
Journal:  Hum Genet       Date:  1990-08       Impact factor: 4.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.